Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fred Mermelstein, Ph.D.

Title
Institution
Department
Address

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chollet J, Mermelstein F, Rocamboli SC, Friend DR. Vaginal tamoxifen for treatment of vulvar and vaginal atrophy: Pharmacokinetics and local tolerance in a rabbit model over 28?days. Int J Pharm. 2019 Oct 30; 570:118691. PMID: 31518632.
    Citations:    Fields:    Translation:Animals
  2. Mermelstein F, Hamilton DA, Wright C, Lacouture PG, Ramaiya A, Carr DB. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPßCD-diclofenac (Dyloject) compared with other diclofenac formulations. Pharmacotherapy. 2013 Oct; 33(10):1012-21. PMID: 23744759.
    Citations: 6     Fields:    Translation:Humans
  3. Christensen K, Daniels S, Bandy D, Ernst CC, Hamilton DA, Mermelstein FH, Wang J, Carr DB. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesth Prog. 2011; 58(2):73-81. PMID: 21679043; PMCID: PMC3198130.
    Citations: 11     Fields:    Translation:Humans
  4. Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause. 2009 Sep-Oct; 16(5):978-83. PMID: 19390463.
    Citations: 7     Fields:    Translation:Humans
  5. Christensen KS, Cohen AE, Mermelstein FH, Hamilton DA, McNicol E, Babul N, Carr DB. The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model. Anesth Analg. 2008 Dec; 107(6):2018-24. PMID: 19020153.
    Citations: 4     Fields:    Translation:Humans
  6. Stoker DG, Reber KR, Waltzman LS, Ernst C, Hamilton D, Gawarecki D, Mermelstein F, McNicol E, Wright C, Carr DB. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery. Pain Med. 2008 Jan-Feb; 9(1):3-12. PMID: 18254761.
    Citations: 3     Fields:    Translation:Humans
  7. Leeson RM, Harrison S, Ernst CC, Hamilton DA, Mermelstein FH, Gawarecki DG, Moshman M, Carr DB. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than voltarol for postoperative dental pain. Reg Anesth Pain Med. 2007 Jul-Aug; 32(4):303-10. PMID: 17720114.
    Citations: 11     Fields:    Translation:Humans
  8. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, Firestone L, Lavin PT, Mermelstein F. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain. 2004 Mar; 108(1-2):17-27. PMID: 15109503.
    Citations: 41     Fields:    Translation:HumansCTClinical Trials
  9. Reinberg D, Orphanides G, Ebright R, Akoulitchev S, Carcamo J, Cho H, Cortes P, Drapkin R, Flores O, Ha I, Inostroza JA, Kim S, Kim TK, Kumar P, Lagrange T, LeRoy G, Lu H, Ma DM, Maldonado E, Merino A, Mermelstein F, Olave I, Sheldon M, Shiekhattar R, Zawel L, et al. The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harb Symp Quant Biol. 1998; 63:83-103. PMID: 10384273.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  10. Mermelstein F, Yeung K, Cao J, Inostroza JA, Erdjument-Bromage H, Eagelson K, Landsman D, Levitt P, Tempst P, Reinberg D. Requirement of a corepressor for Dr1-mediated repression of transcription. Genes Dev. 1996 Apr 15; 10(8):1033-48. PMID: 8608938.
    Citations: 59     Fields:    Translation:HumansAnimalsCells
  11. Shiekhattar R, Mermelstein F, Fisher RP, Drapkin R, Dynlacht B, Wessling HC, Morgan DO, Reinberg D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature. 1995 Mar 16; 374(6519):283-7. PMID: 7533895.
    Citations: 160     Fields:    Translation:HumansCells
  12. Yeung KC, Inostroza JA, Mermelstein FH, Kannabiran C, Reinberg D. Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class II gene transcription. Genes Dev. 1994 Sep 01; 8(17):2097-109. PMID: 7958881.
    Citations: 47     Fields:    Translation:HumansAnimalsCells
  13. Ma D, Watanabe H, Mermelstein F, Admon A, Oguri K, Sun X, Wada T, Imai T, Shiroya T, Reinberg D, et al. Isolation of a cDNA encoding the largest subunit of TFIIA reveals functions important for activated transcription. Genes Dev. 1993 Nov; 7(11):2246-57. PMID: 8224850.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  14. Laskin JD, Mermelstein FH, Heindel ND, Ron Y. Selective inactivation of lymphocytes after psoralen/ultraviolet light (PUVA) treatment without affecting systemic immune responses. J Leukoc Biol. 1993 Aug; 54(2):138-44. PMID: 7689628.
    Citations: 1     Fields:    Translation:AnimalsCells
  15. Inostroza JA, Mermelstein FH, Ha I, Lane WS, Reinberg D. Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell. 1992 Aug 07; 70(3):477-89. PMID: 1339312.
    Citations: 166     Fields:    Translation:HumansCells
  16. Faaland CA, Mermelstein FH, Hayashi J, Laskin JD. Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity. Mol Cell Biol. 1991 May; 11(5):2697-703. PMID: 1850101.
    Citations: 6     Fields:    Translation:HumansCells
  17. Frackelton AR, Posner M, Kannan B, Mermelstein F. Generation of monoclonal antibodies against phosphotyrosine and their use for affinity purification of phosphotyrosine-containing proteins. Methods Enzymol. 1991; 201:79-92. PMID: 1719350.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  18. Merino A, Buckbinder L, Mermelstein FH, Reinberg D. Phosphorylation of cellular proteins regulates their binding to the cAMP response element. J Biol Chem. 1989 Dec 15; 264(35):21266-76. PMID: 2556400.
    Citations: 14     Fields:    Translation:HumansCells
  19. Mermelstein FH, Abidi TF, Laskin JD. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment. Mol Pharmacol. 1989 Dec; 36(6):848-55. PMID: 2557535.
    Citations: 8     Fields:    Translation:HumansCells
  20. Mermelstein FH, Flores O, Reinberg D. Initiation of transcription by RNA polymerase II. Biochim Biophys Acta. 1989 Sep 21; 1009(1):1-10. PMID: 2675975.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mermelstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (165)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.